Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) syndrome associated with azithromycin presenting like septic shock: a case report by Narin Sriratanaviriyakul et al.
JOURNAL OF MEDICAL
CASE REPORTS
Sriratanaviriyakul et al. Journal of Medical Case Reports 2014, 8:332
http://www.jmedicalcasereports.com/content/8/1/332CASE REPORT Open AccessDrug reaction with eosinophilia and systemic
symptoms syndrome (DRESS) syndrome
associated with azithromycin presenting like
septic shock: a case report
Narin Sriratanaviriyakul1,2,3*, Lam-Phuong Nguyen1,2,3, Mark C Henderson2 and Timothy E Albertson1,2,3Abstract
Introduction: Drug reaction with eosinophilia and systemic symptoms syndrome is a potentially life-threatening
cutaneous hypersensitivity reaction characterized by extensive mucocutaneous eruption, fever, hematologic
abnormalities including eosinophilia and/or atypical lymphocytosis, and extensive organ involvement. The drugs
most often responsible for causing drug reaction with eosinophilia and systemic symptoms syndrome are
anticonvulsants, antimicrobial agents and antipyretic or anti-inflammatory analgesics. Although azithromycin is
widely prescribed in clinical practice, serious cutaneous reactions from this agent have been rarely described. We
report the first adult case of drug reaction with eosinophilia and systemic symptoms syndrome associated with
azithromycin.
Case presentation: A 44-year-old previously healthy Caucasian man with history of tobacco use presented to his
primary care physician with fever and productive cough. He was prescribed azithromycin, promethazine hydrochloride
and dextromethorphan hydrobromide syrup. One week later, he developed a blistering erythematous rash over both
hands, which over the next two weeks spread to involve nearly his entire body surface, sparing only his face. He was
admitted to an outside hospital with signs of systemic inflammatory response syndrome and severe sepsis, presumably
from a skin infection. Despite aggressive therapy he deteriorated, with worsening diffuse erythema, and was transferred
to our institution. He developed multiple organ failure requiring ventilatory and hemodynamic support. Pertinent
laboratory studies included a leukocytosis with a white blood cell count of 17.6×109/L and 47% eosinophils. A skin
biopsy showed evidence of spongiotic lichenoid dermatitis with eosinophils and neutrophils, compatible with a
systemic drug-induced hypersensitivity reaction. Our patient was started on high-dose steroids and showed dramatic
improvement within 48 hours.
Conclusions: We report the first adult case of drug reaction with eosinophilia and systemic symptoms syndrome
associated with azithromycin exposure. Clinicians should be aware of this potentially devastating complication from
this commonly prescribed medication.
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Cutaneous hypersensitivity reactions range in severity,
from mild reactions to severe cutaneous adverse reactions,
or SCARs. SCARs include a spectrum of disease from ery-
thema multiforme (EM) to drug reaction with eosinophilia
and systemic symptoms (DRESS) to toxic epidermal ne-
crolysis (TEN), the most serious form of drug reaction.
Mild adverse cutaneous reactions to drugs are common,
occurring in up to 2% to 3% of all hospitalized patients
[1]. Of all the cutaneous adverse reaction, 2% of cases are
severe and very few are fatal [2].
DRESS syndrome is a potentially life-threatening reac-
tion characterized by extensive mucocutaneous eruption,
fever, hematologic abnormalities including eosinophilia
and/or atypical lymphocytosis, and extensive internal
organ involvement [3]. Long-term sequelae and multiple
organ involvement include myocarditis or pericarditis,
interstitial nephritis, necrotizing granulomatous vasculitis,
encephalitis or meningitis, as well as shock and respiratory
distress syndrome. The drugs most often responsible are
anticonvulsants (mostly aromatase derivatives), antimicro-
bial agents, particularly penicillin and sulfonamide-based
agents, and antipyretic/anti-inflammatory analgesics [2,4].
DRESS syndrome has a latency onset, characteristically
occurring within two to six weeks after initial exposure to
the inciting drug. In a few reported cases, the syndrome
becomes persistent despite discontinuation of the culprit
drug [5].
Azithromycin is widely prescribed for acute respiratory
tract infection. The majority of adverse events from azi-
thromycin are mild to moderate in severity and related
to the gastrointestinal tract. Drug rash is observed in
approximately 6% of cases [6]. However, severe cutaneous
reactions have been rarely reported and none have devel-
oped DRESS syndrome according to our literature search.
Here we report the potential first case of DRESS syndrome
associated with azithromycin.
Case presentation
A 44-year-old otherwise healthy Caucasian man, with a
past medical history of anxiety and 15 pack year tobacco
use, initially presented to his primary care physician with
several days onset of fevers, congestion and cough. He
was prescribed azithromycin, promethazine hydrochloride
and dextromethorphan hydrobromide syrup. One week
later, the patient developed an acute diffuse blistering mor-
billiform erythematous rash involving bilateral hands,
which was extremely pruritic and associated with high-
grade fever. Within two weeks, the rash spread to involve
nearly his entire body surface, sparing only his face. He
presented to an outside hospital with persistent fever, rash,
and hypotension consistent with systemic inflammatory
response syndrome. He was treated for severe sepsis and
presumptive superimposed skin infection with vancomycinand aztreonem, given his history of penicillin allergy. Des-
pite aggressive therapy, the patient rapidly deteriorated
with worsening skin involvement, and was subsequently
transferred to our institution for higher level care.
Upon arrival, his vital signs were temperature of 38.2°C,
blood pressure of 95/20mmHg, heart rate 68 beats/min,
respiratory rate 20 breaths/min, and oxygen saturation
95% on 2L nasal canula. Shortly thereafter, our patient
became hypotensive despite aggressive fluid resuscitation
and was started on norepinephrine. Our patient was sub-
sequently intubated due to worsening level of conscious-
ness. A physical examination revealed an ill-appearing
sedated man with evidence of generalized ill-defined
coalescing erythema and diffuse pinpoint petechiae. A
pulmonary examination was notable for bilateral crackles
and diffuse rhonchi and a cardiovascular examination was
normal except for tachycardia. There was no lymphaden-
opathy. A detailed skin examination (Figure 1) revealed
keratotic desquamation of his palms and soles. His lips
and oral mucosa were dry with some cracking of vermil-
ion lips but no bullae. His tongue was diffusely red. His
conjunctivae were injected. There were no vesicles, bullae,
or target lesions seen. The Nikolsky sign was negative.
Laboratory studies revealed leukocytosis with a white
blood cell count of 17.6×109/L with 47% eosinophils, 33%
neutrophils, 5% bands, and 12% lymphocytes as well as
thrombocytopenia of 117×109/L. No atypical lymphocytes
were seen on the peripheral blood smear or manual dif-
ferential. His blood chemistry test results were notable
for blood urea nitrogen of 21.4mmol/L, serum creatinine
229μmol/L, albumin 21g/L, alkaline phosphatase 188μg/L,
aspartate aminotransaminase 58IU/mL, and alanine ami-
notransferase 37IU/mL. Serological test results including
HIV titer, leptospira antibody, and streptolysin O antibody
were all nonreactive. His blood cultures, urine culture,
herpes simplex wound culture, as well as varicella zoster
wound cultures were all unremarkable. Coccidioides ser-
ology was negative. His chest X-ray was consistent with
pulmonary edema (Figure 2). Results from a diagnostic
bronchoscopy showed evidence of diffuse mucosal hype-
remia from the trachea through the subsegmental bronchi
but no sloughing. Bronchial washing studies including
bacterial, viral and fungal cultures, as well as pneumocys-
tis jiroveci DFA, were all unremarkable.
Despite an exhaustive workup noted above and con-
sultation with dermatology, infectious disease, ophthal-
mology, pulmonary and burn specialists, no clear etiology
was identified. Over the next several days, he con-
tinued to worsen despite broad-spectrum antibiotics in-
cluding vancomycin, meropenem and clindamycin. He
developed low-grade disseminated intravascular coagula-
tion (DIC), worsening leukocytosis, worsening renal failure
as well as persistent hypotension requiring high levels of
norepinephrine.
Figure 1 (A) Left leg, (B) left foot, (C) right hand and (D) trunk with ill-defined coalescing erythema from head to toe with diffuse
pinpoint petechiae. Keratotic desquamation of palms and soles.
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evidence of spongiotic lichenoid dermatitis with eosino-
phils and neutrophils (Figures 3 and 4), compatible
with systemic drug hypersensitivity reaction. No evi-
dence of vasculitis was seen on histopathology. Our
patient was started on high-dose steroids and all antibi-
otics were discontinued, given no convincing evidence ofFigure 2 Chest X-ray showing pulmonary edema.infection. He was weaned off norepinephrine and extu-
bated shortly thereafter. His fever resolved and his
generalized body rash dramatically improved over
the course of 48 hours with supportive treatment
(Figure 5). Our patient subsequently made a full recov-
ery after an additional week of rehabilitation and was
discharged home.Figure 3 Spongiotic and interface dermatitis with eosinophils
(hematoxylin and eosin, ×200).
Figure 4 Eosinophilic spongiosis (short arrow) and a necrotic/
apoptotic keratinocyte (long arrow). (Hematoxylin and eosin, ×600).
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DRESS syndrome is a severe drug reaction with a mortality
rate up to 10% despite accurate diagnosis and removal
of the offending agent. Diagnosis is challenging and often
delayed, given its variable presentation. Currently, thereFigure 5 (A and B) Our patient’s left foot with residual superficial ery
involving fingernails. (D) Faint erythematous rash involving the chest, abdoare no accurate diagnostic criteria for DRESS but it is
a syndrome diagnosed by exclusion. The main clinical
features are rash, fever, hematological abnormalities
and organ involvement, all of which can be nonspecific.
The RegiSCAR scoring system has been recently de-
veloped to delineate each of severe cutaneous adverse
reactions (SCARs) as distinct entities [7]. The RegiSCAR
scoring system was designed to grade suspected cases of
DRESS as ‘no’, ‘possible’, ‘probable’ or ‘definite’. DRESS is
considered as definite in our case given that other causes
of febrile eruption with eosinophilia and liver involvement
were ruled out. We suspect that azithromycin is likely the
culprit medication in this scenario. Promethazine may also
produce drug reactions, but the association with DRESS
syndrome has not been reported. There are two avail-
able methods of confirming the culprit drug of DRESS
syndrome: skin patch tests and lymphocyte transform-
ation tests [8]. Unfortunately, neither is widely accepted
or used.
According to one recent review of 172 DRESS cases,
there are 44 drugs associated with DRESS [9]. Of these, the
most frequently reported were carbamazepine, allopurinol,
sulfasalazine, phenobarbital, lamotrigine and nevirapine.thematous rash. (C) Inflammation extending into bilateral hands and
men and trunk.
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adults. Thus far, there have been only two reported
pediatric cases of DRESS associated with azithromycin
[10,11]. One of the cases was also associated with
Epstein-Barr virus (EBV) primary infection. Pursnani
et al. reported a case of fulminant myocarditis in an
adult associated with azithromycin [12], which was pre-
sumed to be DRESS syndrome; however, the RegiSCAR
scoring system was not reported.
The pathophysiology of DRESS syndrome has not
been fully elucidated. Different mechanisms have been
implicated, including detoxification defects leading to
reactive metabolite formation and subsequent immuno-
logical reactions, slow acetylation, and reactivation of
human herpes, including EBV and human herpesvirus
(HHV)-6 and -7 [9]. The association of HHV-6 infection
or reactivation and severe DRESS syndrome has also
been reported [13]. It is postulated that HHV-6 may
interfere with some of the enzymes responsible for drug
detoxification. The virus itself could also be responsible
for the skin lesions and some of the visceral involvement
[13]. The recent studies suggest that HHV-6 reactivation
activates CD8+ T lymphocytes causing it to secrete cyto-
kines [14].
There are no consensus guidelines on the management
of DRESS syndrome. The mainstay of treatment is dis-
continuing the culprit drug. The use of systemic steroids
is controversial including the route of administration
and dosing [9].Conclusions
In summary, we report the first adult case of definite
DRESS syndrome associated with azithromycin exposure.
Early recognition and prompt removal of the culprit agent
is the treatment of choice.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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